...
首页> 外文期刊>Emerging Infectious Diseases >Carbapenemase-producing Klebsiella pneumoniae and Hematologic Malignancies (http://wwwnc.cdc.gov/eid/article/20/7/13-0094)
【24h】

Carbapenemase-producing Klebsiella pneumoniae and Hematologic Malignancies (http://wwwnc.cdc.gov/eid/article/20/7/13-0094)

机译:产生碳青霉烯酶的肺炎克雷伯菌和血液系统恶性肿瘤(http://wwwnc.cdc.gov/eid/article/20/7/13-0094)

获取原文

摘要

To the Editor: Until a few years ago, the most frequent microbiologically documented cause of severe bloodstream infections among patients with hematologic malignancies was gram-positive bacteria (1). However, over the years, gram-negative bacteria have become the main infectious cause of death among patients with hematologic malignancies, and rates of different phenotypes associated with antimicrobial drug resistance are increasing (2). This trend could be the result of increasing empirical use of antimicrobial drug therapy and prophylaxis and use of new, more effective antimicrobial drugs. In particular, over the past few years at our hospital (Agostino Gemelli Teaching Hospital, Rome, Italy), we have observed a progressive increase in bloodstream infections caused by Klebsiella pneumoniae carbapenemase–producing K. pneumoniae (KPC-Kp), which are responsible for a dramatic new scenario.
机译:致编者:直到几年前,血液学上恶性肿瘤患者中微生物学记载的严重血液感染的最常见原因是革兰氏阳性细菌(1)。然而,多年来,革兰氏阴性细菌已成为血液系统恶性肿瘤患者死亡的主要感染原因,并且与抗菌药物耐药性相关的不同表型发生率也在增加(2)。这种趋势可能是由于越来越多的经验性使用抗菌药物疗法以及预防和使用新的,更有效的抗菌药物的结果。尤其是在过去几年中,在我们医院(意大利罗马的Agostino Gemelli教学医院)中,我们观察到由产生肺炎克雷伯菌碳青霉烯酶的肺炎克雷伯菌(KPC-Kp)引起的血液感染逐渐增加。为戏剧性的新场景。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号